Sort
25,944 grants matching “neurodegeneration”
ROS driven mitochondrial-telomere dysfunction during environmental stress
$523,668Bennett Van Houten · University Of Pittsburgh At Pittsburgh · R33 · FY2019 · ES
Establishing Apoptotic Thresholds: Insights from Neurons and Stem Cells to Cancer
$523,601Mohanish Deshmukh · Univ Of North Carolina Chapel Hill · R35 · FY2017 · GM
Molecular basis of lysosomal dysfunction in Alzheimer's disease and approaches to therapeutic remediation
$523,587Ralph A. Nixon · Nathan S. Kline Institute For Psych Res · P01 · FY2021 · AG
Regulation of Gene Expression During Stress
$523,459Maria Hatzoglou · Case Western Reserve University · R01 · FY2018 · DK
Structural and functional investigations on synaptic vesicular transporters
$523,387Chia-Hsueh Lee · St. Jude Children'S Research Hospital · R01 · FY2024 · NS
Structural and functional investigations on synaptic vesicular transporters
$523,387Chia-Hsueh Lee · St. Jude Children'S Research Hospital · R01 · FY2025 · NS
Mechanisms of type I interferon neuropathology following traumatic brain injury
$523,317Elizabeth Newell · University Of Iowa · R01 · FY2023 · NS
Proteostasis dysregulation and the development of Alzheimer's-like neurodegeneration and dementia in Down syndrome
$523,313Domenico Pratico · Temple Univ Of The Commonwealth · R01 · FY2023 · AG
A role for the p75 neurotrophin receptor in Schwann cell regulation of sensory neurons
$523,308Bruce D Carter · Vanderbilt University · R01 · FY2018 · NS
Cell autonomous and non-autonomous mechanisms in Alzheimer's disease and related dementias
$523,285Lisa M. Ellerby · Buck Institute For Research On Aging · P01 · FY2021 · AG
Alzheimer's tauopathy phenotype and the microRNA22-3p: implication for pathogenesis
$523,202Domenico Pratico · Temple Univ Of The Commonwealth · R01 · FY2024 · AG
Mechanisms of motor neuron toxicity in Kennedy disease
$523,094Andrew P Lieberman · University Of Michigan At Ann Arbor · R01 · FY2020 · NS
Role of arginylation in prevention of alpha synuclein-driven neurodegeneration
$523,077Anna S Kashina · University Of Pennsylvania · R01 · FY2020 · NS
The role of Mnbk in DS brain development and aging
$523,045Jerzy Wegiel · Institute For Basic Res In Dev Disabil · R01 · FY2006 · HD
Oxidative Stress, Immune Activation, and Therapeutic Targeting in HIV/HAND
$522,974Dennis Larry Kolson · University Of Pennsylvania · R01 · FY2016 · MH
Validating the New Criteria for Preclinical Alzheimer's disease
$522,972Clifford Jack · Mayo Clinic Rochester · R01 · FY2016 · AG
Caspases in Inflammatory Cell Death Networks
$522,895Guy S Salvesen · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2018 · GM
Caspases in Inflammatory Cell Death Networks
$522,895Guy S Salvesen · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2017 · GM
RNA Targeted Drug Discovery and Development for Parkinson Disease
$522,761M. Maral Mouradian · Rbhs-Robert Wood Johnson Medical School · UG3 · FY2020 · NS
Mechanisms of Novel Regulators of Proteotoxicity and Quality Control Associated with ALS/FTD
$522,739Jiou Wang · Johns Hopkins University · R01 · FY2025 · NS
Experimental Creutzfeldt Jacob Disease
$522,666Laura Manuelidis · Yale University · R01 · FY2009 · NS
Enzymes of O-GlcNAc cycling linked to type-2 diabetes and neurodegeneration
$522,660John A. Hanover · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2010 · DK
SCHIZOPHRENIA--PSYCHOPATHOLOGY AND HETEROGENEITY
$522,625Harvard University (Medical School) · R01 · FY2003 · MH
Mechanisms of non-IgE Mast Cell Activation by Environmental Particulates
$522,599Jared Michael Brown · University Of Colorado Denver · R01 · FY2022 · ES
Molecular signatures of Parkinsons disease in the gut and brain
$522,500Patrik Brundin · Van Andel Research Institute · R21 · FY2019 · NS